January 24, 2026

#chemotherapy — Saturday, January 24, 2026 (2 items)

hot top new

0		ℹ	Nivolumab added to cisplatin and radiotherapy versus cisplatin and radiotherapy alone after surgery for people with squamous cell carcinoma of the head and neck at a high risk of relapse (GORTEC 2018-01 NIVOPOST-OP): a randomised, open-label, phase 3 trial. (linkinghub.elsevier.com)	Bourhis J … Tao Y The Lancet 2026-01-24	#cancer #clinical trial #immunotherapy #chemotherapy #radiotherapy
0		ℹ	Savolitinib plus osimertinib versus chemotherapy for advanced, EGFR mutation-positive, MET-amplified non-small-cell lung cancer in China (SACHI): interim analysis of a multicentre, open-label, phase 3 randomised controlled trial. (linkinghub.elsevier.com)	Lu S … Su W The Lancet 2026-01-24	#clinical trial #chemotherapy #nsclc #tyrosine kinase inhibitor #met amplification